Replay of the Press Conference on ColdZyme, March 5, 2025
14 March 2025
On March 5, 2025, Enzymatica held a digital press conference to mark the publication of two independent research studies on ColdZyme in the scientific journal The Journal of Physiology.
During the event, Professor Glen Davison from the University of Kent and Professor Doris Wilflingseder from the Medical University of Vienna presented their findings. The studies show that ColdZyme effectively reduces viral load and shortens the duration of upper respiratory tract infections. Participants who used ColdZyme experienced both milder symptoms and fewer sick days compared to the placebo group.
Following the presentations, Enzymatica’s CEO Claus Egstrand and Chairman of the Board Bengt Baron provided a company update. They highlighted how the new research findings reinforce the company’s strategic direction and support its plans for continued international expansion.
Would you like to watch the press conference? The full recording is available here:
Replay of the Press Conference on ColdZyme